Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis

S Usman, NH Waseem, TKN Nguyen, S Mohsin… - Cancers, 2021 - mdpi.com
Simple Summary Vimentin is an important filamentous protein providing structural and
functional support to the cell. During initial stages of cancer development, vimentin …

Targeting hypoxic tumor microenvironment in pancreatic cancer

J Tao, G Yang, W Zhou, J Qiu, G Chen, W Luo… - Journal of hematology & …, 2021 - Springer
Attributable to its late diagnosis, early metastasis, and poor prognosis, pancreatic cancer
remains one of the most lethal diseases worldwide. Unlike other solid tumors, pancreatic …

[HTML][HTML] Vimentin on the move: new developments in cell migration

RA Battaglia, S Delic, H Herrmann, NT Snider - F1000Research, 2018 - ncbi.nlm.nih.gov
The vimentin gene (VIM) encodes one of the 71 human intermediate filament (IF) proteins,
which are the building blocks of highly ordered, dynamic, and cell type-specific fiber …

Vimentin intermediate filaments as potential target for cancer treatment

K Strouhalova, M Přechová, A Gandalovičová… - Cancers, 2020 - mdpi.com
Intermediate filaments constitute the third component of the cellular skeleton. Unlike actin
and microtubule cytoskeletons, the intermediate filaments are composed of a wide variety of …

[HTML][HTML] Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein

M Liu, J Zhong, Z Zeng, K Huang, Z Ye, S Deng… - Theranostics, 2019 - ncbi.nlm.nih.gov
Rationale: Emerging evidences have highlighted the critical roles of lncRNAs in human
cancer development. The work sought to assess the biological role and potential underlying …

Targeting vimentin: A multifaceted approach to combatting cancer metastasis and drug resistance

A Tabatabaee, B Nafari, A Farhang, A Hariri… - Cancer and Metastasis …, 2024 - Springer
This comprehensive review explores vimentin as a pivotal therapeutic target in cancer
treatment, with a primary focus on mitigating metastasis and overcoming drug resistance …

Hypoxia and pancreatic ductal adenocarcinoma

A Yamasaki, K Yanai, H Onishi - Cancer letters, 2020 - Elsevier
Chemotherapy and immunotherapy for pancreatic ductal adenocarcinoma (PDAC) have
limited success. One reason for this is thought to be the cancer microenvironment …

Crosstalk of MicroRNAs and oxidative stress in the pathogenesis of cancer

C Lu, D Zhou, Q Wang, W Liu, F Yu… - … Medicine and Cellular …, 2020 - Wiley Online Library
Oxidative stress refers to an imbalance between reactive oxygen species (ROS) generation
and body's capability to detoxify the reactive mediators or to fix the relating damage …

Pre-clinical and clinical applications of small interfering RNAs (siRNA) and co-delivery systems for pancreatic cancer therapy

S Mirzaei, MH Gholami, HL Ang, F Hashemi, A Zarrabi… - Cells, 2021 - mdpi.com
Pancreatic cancer (PC) is one of the leading causes of death and is the fourth most
malignant tumor in men. The epigenetic and genetic alterations appear to be responsible for …

Hypoxia-regulated microRNAs: the molecular drivers of tumor progression

S Sawai, PF Wong, TS Ramasamy - Critical Reviews in …, 2022 - Taylor & Francis
Hypoxia is a common feature of the tumor microenvironment (TME) of nearly all solid tumors,
leading to therapeutic failure. The changes in stiffness of the extracellular matrix (ECM), pH …